-
Love ‘em or hate ‘em, narrow networks are drawing scrutiny
Health insurers’ efforts to keep costs low by using narrow networks are drawing increased scrutiny. Such oversight may be inevitable…
-
CMS withdraws contentious parts of proposal to change prescription drug program
Perhaps the federal Centers for Medicare & Medicaid Services (CMS) learned a lesson over the past few weeks when it…
-
Senate Finance Committee members say CMS should reconsider Medicare drug proposal
Members of the Senate Finance Committee are urging the federal Centers for Medicare & Medicaid Services (CMS) to reconsider a…
-
Medicare Advantage proposal outlines strategies to promote value-based insurance and patient engagement
Buried deep in a proposal from the federal Centers for Medicare & Medicaid Services (CMS) last week was a proposal…
-
House committee grills CMS executive on proposal to revise Medicare drug plan
A plan from the federal Centers for Medicare & Medicaid Services to eliminate protections for certain classes of drugs ran…
-
Seeking to contain costs for six protected drug classes, CMS faces wide opposition
Patient care advocates, drug companies, and both Republicans and Democrats are arguing against a proposal from the federal Centers for…
-
Movement away from fee-for-service reimbursements has begun
Among health plan executives, there’s a lot of talk about moving from volume to value. But identifying what this expression…
-
Judge cites journalists’ work among reasons to unseal pricing data
Two rulings in one week in a case involving an Idaho hospital’s purchase of a physician group gave health care…
-
Court ruling may signal tougher stance on hospital-physician ventures
One of the most significant trends in health care over the past few years has been the merger of physician…
-
Journalist explains what to expect from new mental health parity rules
Later this year, health plans will be under new mental health parity rules affecting how insurers should cover patients with…